JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 603K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walensky, L. D.
Right arrow Articles by Snyder, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walensky, L. D.
Right arrow Articles by Snyder, S. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/1998//143 $5.00
The Journal of Cell Biology, Volume 141, Number 1, , 1998 143-153


Regular Articles

The 13-kD FK506 Binding Protein, FKBP13, Interacts with a Novel Homologue of the Erythrocyte Membrane Cytoskeletal Protein 4.1



Loren D. Walensky*,{ddagger}, Philippe Gascard||, Michael E. Field*, Seth Blackshaw*, John G. Conboy||, Narla Mohandas||, and Solomon H. Snyder*,{ddagger},§

* Department of Neuroscience, {ddagger} Department of Pharmacology and Molecular Sciences, and § Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland, 21205; and || Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, Berkeley, CA 94720

We have identified a novel generally expressed homologue of the erythrocyte membrane cytoskeletal protein 4.1, named 4.1G, based on the interaction of its COOH-terminal domain (CTD) with the immunophilin FKBP13. The 129-amino acid peptide, designated 4.1G–CTD, is the first known physiologic binding target of FKBP13. FKBP13 is a 13-kD protein originally identified by its high affinity binding to the immunosuppressant drugs FK506 and rapamycin (Jin, Y., M.W. Albers, W.S. Lane, B.E. Bierer, and S.J. Burakoff. 1991. Proc. Natl. Acad. Sci. USA. 88:6677– 6681); it is a membrane-associated protein thought to function as an ER chaperone (Bush, K.T., B.A. Henrickson, and S.K. Nigam. 1994. Biochem. J. [Tokyo]. 303:705–708). We report the specific association of FKBP13 with 4.1G–CTD based on yeast two-hybrid, in vitro binding and coimmunoprecipitation experiments. The histidyl-proline moiety of 4.1G–CTD is required for FKBP13 binding, as indicated by yeast experiments with truncated and mutated 4.1G–CTD constructs. In situ hybridization studies reveal cellular colocalizations for FKBP13 and 4.1G–CTD throughout the body during development, supporting a physiologic role for the interaction. Interestingly, FKBP13 cofractionates with the red blood cell homologue of 4.1 (4.1R) in ghosts, inside-out vesicles, and Triton shell preparations. The identification of FKBP13 in erythrocytes, which lack ER, suggests that FKBP13 may additionally function as a component of membrane cytoskeletal scaffolds.


Abbreviations used in this paper: 4.1G, general protein 4.1; 4.1R, red blood cell protein 4.1; aa, amino acid(s); ala, alanine; arg, arginine; β-gal, β-galactosidase; CTD, COOH-terminal domain; EST, expressed sequence tag; FKBP, FK506 binding protein; GAL4(DB), GAL4 DNA–binding domain; GAL4(TA), GAL4 transactivating domain; gln, glutamine; HA, hemagglutinin; his, histidine; h,m,r4.1G, human, mouse, rat 4.1G; h,m,r4.1R, human, mouse, rat 4.1R; ile, isoleucine; IOV, inside-out vesicle; IP3, inositol 1,4,5-trisphosphate; leu, leucine; MBD, membrane-binding domain; PEG, polyethylene glycol; pro, proline; PVDF, polyvinylene difluoride; RBC, red blood cell; RT, reverse transcription; SABD, spectrin actin-binding domain; ser, serine; trp, tryptophan; val, valine.

Address all correspondence to Solomon H. Snyder, Department of Neuroscience, The Johns Hopkins University School of Medicine, 813 WBSB, 725 North Wolfe Street, Baltimore, MD 21205. Tel.: (410) 995-3024. Fax: (410) 995-3623.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents